This comprehensive perspective underscores gepirone as a paradigmatic example of selective 5-HT<sub>1A</sub> modulation and offers novel insights into the development of targeted treatments for depression and anxiety. The gene discussed is HTR5A; the disease is depressive symptom measurement.